|
|||||||||||||||||||||||||||||||||||||||||||
|
|
Key: Meeting
Showing releases 401-425 out of 948. << < 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 > >>
Public Release: 9-Jul-2012
High-level commission finds an epidemic of bad laws is stifling the global AIDS response Landmark report finds evidence that enforcing punitive laws hinders HIV responses and wastes resources. Commission urgently calls for laws that protect human rights to save lives, save money and end the epidemic. Contact: Benjamin Humphrey Public Release: 9-Jul-2012
Canada's Bill C-31 to change immigration act could severely affect mental health of refugees The Canadian government's proposed Bill C-31 to change the country's immigration act could have serious negative impacts on the mental health of refugees, states a commentary in CMAJ. Contact: Kim Barnhardt Public Release: 9-Jul-2012
Generic drugs key to US overseas HIV relief The President's Emergency Plan for AIDS Relief (PEPfAR) program has spent billions of dollars during the last nine years to provide HIV-related care to millions of people in 15 developing nations. Had the program not overcome a late start in adopting generic drugs, it would never have accomplished that scale of benefit, write Brown University researchers in the journal Health Affairs. Contact: David Orenstein Public Release: 6-Jul-2012
Grant to allow graduate students to research water quantity and quality improvement To address questions on water quantity and quality issues, the University of California, Riverside has received a five-year, $3 million grant from the National Science Foundation. Starting this fall, six or seven graduate students will receive fellowships for two years to conduct doctoral-level research on water-related topics. Each "water scholar" will receive preparation for leadership positions in government and private and nonprofit organizations aimed at improving community health and child development outcomes related to water. Contact: Iqbal Pittalwala Public Release: 6-Jul-2012
E-waste: Annual gold, silver 'deposits' in new high-tech goods worth $21B; less than 15% recovered A staggering 320 tons of gold and more than 7,500 tons of silver are now used annually to make PCs, cell phones, tablet computers and other new electronic and electrical products worldwide, adding more than $21 billion in value each year to the rich fortunes in metals eventually available through "urban mining" of e-waste, UNU and other experts told participants from 12 countries attending the first-ever e-Waste Academy for policymakers and small businesses in Accra, Ghana. Contact: Terry Collins Public Release: 4-Jul-2012
Strawberries activate protection protein to prevent cardiovascular disease Scientists at the University of Warwick have been studying the beneficial effects of strawberries on our cardiovascular health, particularly around how they prevent the development of heart disease and diabetes. Contact: Paul Thornalley Public Release: 4-Jul-2012
Developing world has less than 5 percent chance of meeting UN child hunger target, study estimates Insufficient progress has been made in most developing countries to meet the United Nations' target of halving the proportion of children who suffer from hunger by 2015 compared with 1990 levels, according to a systematic analysis of data on children's height and weight, published today in the Lancet. Contact: Sam Wong Public Release: 4-Jul-2012
New study maps hotspots of human-animal infectious diseases and emerging disease outbreaks A new global study mapping human-animal diseases like tuberculosis and Rift Valley fever finds that an "unlucky" 13 zoonoses are responsible for 2.4 billion cases of human illness and 2.2 million deaths per year. The vast majority occur in low- and middle-income countries. Contact: Jeff Haskins Public Release: 3-Jul-2012
Social bats pay a price: Fungal disease, white-nose syndrome ... extinction? The effect on bat populations of a deadly fungal disease known as white-nose syndrome may depend on how gregarious the bats are during hibernation, scientists have discovered. Contact: Cheryl Dybas Public Release: 3-Jul-2012
New drug prospect offers hope against hookworm infections A drug candidate that is nearing clinical trials against a Latin American parasite is showing additional promise as a cure for hookworm, one of the most widespread and insidious parasites afflicting developing nations, according to a collaborative study at UCSF and Yale University. Contact: Kristen Bole Public Release: 3-Jul-2012
Polio vaccination programs not reaching enough children in Afghanistan and Pakistan New, more effective vaccines are struggling to have an impact in the drive to eradicate polio in Afghanistan and Pakistan because not enough children are being vaccinated, according to a study published in the Lancet medical journal today. Contact: Sam Wong Public Release: 3-Jul-2012
2 studies offer new insights from the front lines of battle against malaria A pair of provocative studies in the July 2012 issue of the American Journal of Tropical and Medicine and Hygiene provides a window into the intense ground war now underway against malaria. Contact: Bridget DeSimone Public Release: 2-Jul-2012
Measuring the uncertainties of pandemic influenza A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza. Contact: Jeanne M. Fair Public Release: 1-Jul-2012
Scripps Research Institute Scientists Develop Alternative to Gene Therapy Scientists at the Scripps Research Institute have discovered a surprisingly simple and safe method to disrupt specific genes within cells. The scientists highlighted the medical potential of the new technique by demonstrating its use as a safer alternative to an experimental gene therapy against HIV infection. Contact: Mika OnoScripps Research Institute scientists develop alternative to gene therapy Public Release: 29-Jun-2012
Clean cookstoves unaffordable to Bangladeshi women Women in rural Bangladesh prefer inexpensive, traditional stoves for cooking over modern ones despite significant health risks, according to a Yale study in the Proceedings of the National Academy of Sciences. Contact: David DeFusco Public Release: 27-Jun-2012
Building a better Rift Valley fever vaccine Researchers have significantly improved an existing experimental vaccine for Rift Valley fever virus, making possible the development of a more effective defense against the dangerous mosquito-borne pathogen. Contact: Jim Kelly Public Release: 26-Jun-2012
Bacterial vaginosis is associated with higher risk of female-to-male transmission of HIV "Previous research has shown that bacterial vaginosis can increase a women's risk of becoming infected with HIV as much as sixty percent. Our study is the first to show that the risk of transmitting HIV is also elevated. Our findings point to the need for additional research to improve the diagnosis and treatment of bacterial vaginosis, which is extremely common in sub-Saharan Africa, the region of the globe with the highest burden of HIV." Contact: Jeff Sheehy Public Release: 25-Jun-2012
7 pharmaceutical companies join academic researchers to speed TB drug discovery Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, have launched a groundbreaking partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB). The partnership, known as the TB Drug Accelerator, will target the discovery of new TB drugs by collaborating on early-stage research. Contact: Daniel Pawson Public Release: 21-Jun-2012
From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates A new technique detected the first published evidence of tuberculosis pathogens in the mouths of macaques living near people in six Asian countries. The method analyses mouth swabs from monkeys to check for tuberculosis DNA. The findings raise the question of interspecies transmission, but the origin of these infections is uncertain. However, the risk of spread to people appears minimal. The test could help protect the health of the world's primate populations. Contact: Leila Gray Public Release: 20-Jun-2012
Controversial vaccine trial should never have been run in India, researchers say Research published today in the Journal of the Royal Society of Medicine raises further questions about a trial of HPV vaccines in India. Contact: Kerry Noble Public Release: 18-Jun-2012
University of Maryland researchers detail 2010 Haitian cholera A new study by an international team of scientists led by researchers from the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine, the Center for Bioinformatics and Computational Biology at the University of Maryland, College Park, and CosmosIDTM Inc., College Park, have found two distinct strains of cholera bacteria may have contributed to the 2010 Haitian cholera outbreak. Their results are published in PNAS June 18, 2012. Contact: Karen Robinson Public Release: 14-Jun-2012
Researchers outline plan to end preventable child deaths in a generation Johns Hopkins Bloomberg School of Public Health researchers outline a strategy and benchmarks for curbing childhood preventable deaths. Contact: Natalie Wood-Wright Public Release: 13-Jun-2012
GAVI boosts global response to measles outbreaks Seeking to address the devastating resurgence of measles, the GAVI Alliance will provide up to an additional $162 million to control and prevent outbreaks in developing countries. This funding will help countries bridge critical gaps in their efforts to build sustainable systems to control this deadly disease. Contact: Dan Thomas Public Release: 13-Jun-2012
New drug-screening method yields long-sought anti-HIV compounds Scientists at the Scripps Research Institute have used a powerful new chemical-screening method to find compounds that inhibit the activity of human immunodeficiency virus (HIV), the virus that causes AIDS. Contact: Mika Ono Public Release: 13-Jun-2012
Clinical trial of human hookworm vaccine begins at Children's National Medical Center Today, the Sabin Vaccine Institute, in partnership with the George Washington University and the Children's National Medical Center, began vaccinating participants for a Phase 1 clinical trial of a novel human hookworm vaccine. The trial will investigate the Na-GST-1 antigen developed by the Sabin Vaccine Institute Product Development Partnership to prevent hookworm infections in endemic areas. Contact: Johanna Harvey
Showing releases 401-425 out of 948. << < 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 > >>
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||